Zhengye Biotechnology Holding (ZYBT) Finished Goods (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Finished Goods for 3 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Finished Goods fell 22.68% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $1.9 million, a 22.68% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 20.29% from the prior year.
• Finished Goods was $1.9 million for Q4 2025 at Zhengye Biotechnology Holding, down from $2.5 million in the prior quarter.
• Over five years, Finished Goods peaked at $2.5 million in Q4 2024 and troughed at $1.9 million in Q4 2025.
• A 3-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods rose 19.65% in 2024 and slipped 22.68% in 2025, its largest moves.
• Over 3 years, Finished Goods stood at $2.1 million in 2023, then rose by 19.65% to $2.5 million in 2024, then retreated by 22.68% to $1.9 million in 2025.
• The last three Finished Goods figures came in at $1.9 million (Q4 2025), $2.5 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.